Trial NCT04612790

View at ClinicalTrials.gov 
Org. Study IDs: D325AC00002
Secondary IDs: 2020-000287-32 2023-505033-27

Last trial update was posted on 2023-11-18

MeSH Interventions

Benralizumab

MeSH Conditions

Pemphigoid, Bullous

Other Conditions

Bullous Pemphigoid

Stopping Reasons

Independent Data Monitoring Committee recommended terminating the study following a pre-planned analysis as the efficacy results did not meet the pre-defined futility guidelines. There were no new safety concerns identified from this analysis.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID